Navigation Links
BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors
Date:1/15/2014

NEW YORK, January 15, 2014 /PRNewswire/ --

BreedIT Corp (OTC: BRDT), through its Israeli subsidiary, BreedIT Ltd., the exclusive worldwide distributor of highly sophisticated agro-breeding solutions for plant breeders and researchers, today announced that on January 7, 2014, the Company's board of directors appointed chemistry and pharmaceutical industry expert Dr. Ben-Zion Weiner as its new member of the board.

From 1975 to 2012, Dr. Weiner held executive positions with Teva Pharmaceutical Industries Ltd (NYSE: TEVA) and its subsidiaries ("Teva"). He was Vice President of Global Products of Teva from 2005 to 2011 where he was responsible for global Generic and Innovative Research and Development.

Dr. Weiner was also a Member of the Core Management Committee.

Dr. Weiner holds a B.Sc. Degree in General Chemistry and Biochemistry, graduating with distinction at the Hebrew University, Jerusalem, a M.Sc. Degree in Organic Chemistry, graduating with distinction at the Hebrew University of Jerusalem, and a Ph.D. Degree from the Hebrew University, Jerusalem. Dr. Weiner did his Post-Doctorate studies at Schering Plough Corporation in Bloomfield, New Jersey, on "Exploratory work of new drugs, research in organic chemistry, and pharmacology." Notable accolades include receiving the Rothschild Prize for Innovation/Export for the development of Copaxone(R) for Multiple Sclerosis and for the development of alpha D3 for Dialysis and Osteoporosis.

Dr. Weiner commented, "I am  pleased with the high potential of BreedIT's technology. My pharmaceutical background will allow me to consult and advise how to maximize future products potential uses, especially in the efforts to pursue opportunities in the Medical Cannabis field."

Itschak Shrem,
'/>"/>

SOURCE BreedIT Corp
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Businessmen Bank on Marijuana as Colorados Green Rush Approaches in the Medical Marijuana Industry with Hemp, Inc. (OTC: HEMP) Leading the Charge
2. Groupe Athena Inc., (OTC: GATA) Reports Audited Financials, Announces Record Revenue & Profits
3. Tegra Medical Appoints New Chief Executive Officer
4. Meditope Biosciences Appoints Prominent Scientific Advisory Board
5. Actavis Appoints Industry Veterans to Lead U.S. Specialty Brands Business Units
6. Analyte Health Appoints Lawrence Leisure to its Advisory Board
7. ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
8. Cardica Appoints Industry Veteran Liam Burns As Vice President, Sales And Marketing
9. PhaseRx Appoints Michael Houston, Ph.D., Vice President, Therapeutics Development
10. Chief Financial Officer Jonathan M. Peacock to Leave Amgen; Company Appoints Michael A. Kelly Acting Chief Financial Officer
11. Zafgen Appoints Chief Commercial Officer and New Member of Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  PTC Therapeutics, ... announce five recipients of its first-ever global awards ... Vision and Empowerment), designed to aid nonprofit organizations ... dystrophy (DMD) community. The announcement is made as ... World Duchenne Awareness Day on Monday, September 7, ...
(Date:9/4/2015)... , September 4, 2015 ... ), a clinical-stage pharmaceutical company focused on the development ... Company will participate in the upcoming Rodman & Renshaw ... September 8-10, 2015 in New York City ... Oramed, will present a corporate overview on September 9, ...
(Date:9/4/2015)... , September 4, 2015 Future ... Allergic Rhinitis drugs - new ... Where is the market for allergic rhinitis drugs ... Visiongain ,s new report shows you potential revenues ... prospects. Our 326 page report provides 273 ...
Breaking Medicine Technology:PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 2PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 3PTC Therapeutics Announces Five Winners In Its First-ever Global Duchenne Muscular Dystrophy Patient Group Award 4Oramed to Present at the Rodman & Renshaw Global Investment Conference 2Oramed to Present at the Rodman & Renshaw Global Investment Conference 3Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7
... Globus Medical, Inc., the largest,privately held spinal ... in motion preservation technology, today announced the completion ... study. The,SECURE(R)-C device is designed to mimic the ... pain and restore function as an alternative to ...
... Siemens Healthcare and,Laboratory Corporation of America(R) Holdings ... non-exclusive agreement to discuss future,possibilities to co-develop ... of,companion diagnostics, metabolic syndrome, oncology and diabetes. ... developing new tests that,could make the biggest ...
Cached Medicine Technology:Globus Medical Completes Enrollment Of SECURE(R)-C Cervical Artificial Disc Clinical Trial 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 2Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 3Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests 4
(Date:9/4/2015)... Los Angeles, CA (PRWEB) , ... September 04, 2015 , ... ... many of the elderly Americans currently being cared for in nursing homes and assisted ... Specifically, the author discussed a personal story in which her father was at one ...
(Date:9/4/2015)... , ... September 04, 2015 , ... According to an ... Journal of the American Dental Association presented data showing that it is safe for ... group of pregnant women that had undergone local anesthesia with a group that hadn’t, ...
(Date:9/4/2015)... Aliso Viejo, CA (PRWEB) , ... September 04, 2015 , ... ... a click of a mouse all within Final Cut Pro X. With TransCel users ... finish. Adjust the frame width, background color, speed method, frame color, inner color, text, ...
(Date:9/4/2015)... California (PRWEB) , ... September 04, 2015 , ... The ... behalf of Tanya De La Paz. , Schmidt National Law Group, a leading ... Northern District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer affiliates ...
(Date:9/4/2015)... , ... September 04, 2015 , ... IVF New England, ... a New Hampshire fertility "ManchVegas Happy Hour" in Manchester for women who wish to ... 2015 at XO on Elm restaurant and lounge, 827 Elm Street, Manchester, NH from ...
Breaking Medicine News(10 mins):Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 2Health News:Op-Ed about Insufficient Care for Elderly Patients Highlights the Advantages of Quality, At-Home Care, says Dr. Michael Farzam 3Health News:Recent Study on Dental Care During Pregnancy Demonstrates How Preventative Dental Care Really is for Everyone, Says Medical Center Dental Care 2Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:IVF New England to Host ManchVegas New Hampshire Fertility Happy Hour on October 15, 2015 in Manchester for Women Who Wish to Learn More About Fertility and Egg Freezing 2
... Dr. Barry Sears, ... that, “The obesity crisis and related problems, such as increases in diabetes and heart disease, ... with anti-inflammatory diets, such as the Zone Diet." , ... New Haven, CT (Vocus) June 15, 2010 -- “A majority ...
... a key player in a signaling pathway involved in the ... may offer hope for new targeted melanoma therapies. ... report that a signaling molecule, known as IKKβ, is essential ... disease. The results, published June 7 in the Journal ...
... outcomes, many patients newly-diagnosed with early-stage lung cancer do ... factors associated with this decision include misunderstandings of the ... with black patients more likely to not have surgery, ... of JAMA . Lung cancer is ...
... is 1.3 times higher for those with MRSA in ... News) -- Cystic fibrosis patients with methicillin-resistant staphylococcus aureus ... than those without the drug-resistant bacteria, researchers have found. ... issue of the Journal of the American Medical ...
... Florida Advisory Council on Radiation Protection has endorsed Target ... protection plan. , ASTRO,s Board of Directors developed Target ... safety and quality assurance projects, which began as part ... goal of the plan is to improve safety and ...
... A new book by researchers at Oregon State University ... viewpoint on all types of animal and plant fossils ... they functioned and behaved, especially at the moment of death. ... of a mother, mating and reproductive instincts, to the behavior ...
Cached Medicine News:Health News:Clear Channel's “Penn Project” Features Dr. Barry Sears, Zone Diet Creator, About Obesity in America 2Health News:Tumor target suggests personalized treatment for melanoma 2Health News:Tumor target suggests personalized treatment for melanoma 3Health News:Study examines reasons patients with early stage lung cancer do not have surgery 2Health News:Study examines reasons patients with early stage lung cancer do not have surgery 3Health News:Drug-Resistant Staph Threatens Cystic Fibrosis Patients 2Health News:Florida radiation council endorses ASTRO patient protection plan 2Health News:A new view of fossils: The behavior of ancient life forms 2
... feature a low implant profile, 0.84mm, for ... single-quadrant insertion is technically simpler and allows ... be installed with less trauma than multiple ... Baerveldt implant were designed to minimize bleb ...
... is lightweight enough to shuttle easily between ... Designed with a goldmann standard 30 cm ... with 79 locations (including 30-2, 24-2, and ... different suprathresholds out to 30. Easyfield ...
The most versatile 90 full field perimeter for static- and kinetic perimetry. It incorporates standard White-on-White and Blue-on-Yellow static perimetry. Octopus 101 covers all the needs in clinics ...
... Designed around the patented Interzeag ... 301 sets the trend in ... Ideal for routine screening and ... performance, accuracy and quality of ...
Medicine Products: